IMC Chicago
ADMA icon

IMC Chicago’s ADMA Biologics ADMA Stock Holding History

IMC Chicago’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Buy
187,300
+67,100
+56% +$1.06M ﹤0.01% 2744
2025
Q4 		$2.19M Buy
120,200
+68,800
+134% +$1.16M ﹤0.01% 2333
2025
Q3 		$754K Buy
51,400
+20,700
+67% +$355K ﹤0.01% 2912
2025
Q2 		$559K Sell
30,700
-1,200
-4% -$24.5K ﹤0.01% 2800
2025
Q1 		$633K Buy
31,900
+16,000
+101% +$277K ﹤0.01% 2534
2024
Q4 		$273K Buy
+15,900
New +$299K ﹤0.01% 3008

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

IMC Chicago's ADMA Position: Q1 2026 in Review

IMC Chicago increased its ADMA Biologics (ADMA) stake by 194% in Q1 2026, buying an estimated $646K and bringing the position to 62,075 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #3924.

IMC Chicago first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • IMC Chicago held 62,075 shares of ADMA Biologics worth $559K as of Q1 2026.
  • IMC Chicago bought 40,964 ADMA Biologics shares in Q1 2026, an estimated $646K.
  • ADMA Biologics made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3924 holding.
  • IMC Chicago first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.